A phase I/II clinical trial of carbon-ion radiotherapy in 12 fractions for prostate cancer
Phase 1
- Conditions
- prostate cancer
- Registration Number
- JPRN-UMIN000003838
- Lead Sponsor
- ational Institute of Radiological Sciences, Network congress of charged particle therapy
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Male
- Target Recruitment
- 45
Inclusion Criteria
Not provided
Exclusion Criteria
1)previous radiation therapy for pelvis 2)expected survival period < 6 months 3)Performance status worse than 2 4)previous treatment other than hormonal therapy for prostate cancer 5)concurrent other malignancy 6)active infection in pelvis 7)not inclusive because of other serious medical or psychological problem
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method incidence of late radiation toxicity
- Secondary Outcome Measures
Name Time Method relapse-free survival rate, overall survival rate, cause-specific survival rate, quality of life assessment